Semaglutide(Zhejiang Apeloa Kangyu Pharma)

司美格鲁肽（浙江普洛康裕制药）

Report date: 2026/03/24 20:00:35

Base Information

Drug NameSemaglutide(Zhejiang Apeloa Kangyu Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesZhejiang Apeloa Kangyu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Apeloa Kangyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A